Home › Multiple Myeloma
Pag-aaral pangklinika para sa Multiple Myeloma na nagre-recruit sa U.S.
238 pag-aaral para sa Multiple Myeloma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY60 pag-aaral
- Boston, MA42 pag-aaral
- Atlanta, GA41 pag-aaral
- Houston, TX38 pag-aaral
- Durham, NC37 pag-aaral
- Nashville, TN32 pag-aaral
- Denver, CO26 pag-aaral
- Columbus, OH24 pag-aaral
- Baldwin Park, CA23 pag-aaral
- St. Louis, MO23 pag-aaral
- Rochester, MN23 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA22 pag-aaral
- Edison, NJ22 pag-aaral
- Chicago, IL22 pag-aaral
- Salt Lake City, UT21 pag-aaral
- Miami, FL21 pag-aaral
- Charlotte, NC21 pag-aaral
- Milwaukee, WI21 pag-aaral
- Queens, NY20 pag-aaral
- Detroit, MI19 pag-aaral
- Jacksonville, FL18 pag-aaral
- Birmingham, AL18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Philadelphia, PA17 pag-aaral
- Cincinnati, OH17 pag-aaral
- Dallas, TX17 pag-aaral
- Omaha, NE16 pag-aaral
- Cleveland, OH16 pag-aaral
- Phoenix, AZ16 pag-aaral
- San Francisco, CA15 pag-aaral
- Cedar Rapids, IA15 pag-aaral
- Tampa, FL15 pag-aaral
- New Haven, CT14 pag-aaral
- New Rochelle, NY14 pag-aaral
- Winston-Salem, NC14 pag-aaral
- Clifton, NJ14 pag-aaral
- Irvine, CA13 pag-aaral
- Staten Island, NY13 pag-aaral
- East Norwalk, CT13 pag-aaral
Ayos sa estado
- Alabama22 pag-aaral
- Arizona27 pag-aaral
- Arkansas9 pag-aaral
- California70 pag-aaral
- Colorado36 pag-aaral
- Connecticut18 pag-aaral
- Delaware4 pag-aaral
- District of Columbia10 pag-aaral
- Florida55 pag-aaral
- Georgia49 pag-aaral
- Idaho3 pag-aaral
- Illinois31 pag-aaral
- Indiana19 pag-aaral
- Iowa17 pag-aaral
- Kansas12 pag-aaral
- Kentucky15 pag-aaral
- Louisiana9 pag-aaral
- Maine3 pag-aaral
- Maryland25 pag-aaral
- Massachusetts44 pag-aaral
- Michigan26 pag-aaral
- Minnesota29 pag-aaral
- Missouri26 pag-aaral
- Montana4 pag-aaral
- Nebraska18 pag-aaral
- New Hampshire4 pag-aaral
- New Jersey38 pag-aaral
- New Mexico5 pag-aaral
- New York75 pag-aaral
- North Carolina52 pag-aaral
- North Dakota5 pag-aaral
- Ohio46 pag-aaral
- Oklahoma3 pag-aaral
- Oregon20 pag-aaral
- Pennsylvania24 pag-aaral
- Rhode Island6 pag-aaral
- South Carolina9 pag-aaral
- South Dakota3 pag-aaral
- Tennessee32 pag-aaral
- Texas53 pag-aaral
- Utah21 pag-aaral
- Virginia20 pag-aaral
- Washington30 pag-aaral
- West Virginia3 pag-aaral
- Wisconsin28 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07409246A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07391657Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06904066Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01676805A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT04973605Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06948084Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 72 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03412877A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05652335A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06500884A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07336472Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07609940A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05201781A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07393282A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06768489A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07258511Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Nagre-recruitPhase 2
Edad 60 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06052826A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05552222A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07073547A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07149857A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07518186A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04634552A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05623020A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07477587Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.